CHAMPIONS ONCOLOGY, INC. (CSBR) Current Ratio
- Current ratio · latest quarter: Value 1.03×; Formula and calculation Current assets / current liabilities..
Current ratio
Overview →Financial period ending 2026-07-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Current ratio · latest quarter | 1.03× | Current assets / current liabilities. $19.29M ÷ $18.73M ≈ 1.03× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Current assets | 19.29M USD | Assets, Current |
| Current obligations | 18.73M USD | Liabilities, Current |
| Cash and equivalents | 4.36M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 13.60M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory | (m) | |
| Payables | 5.63M USD | Accounts Payable, Current |
| Borrowing debt due within one year | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Current assets (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory (USD) | Payables (USD) | Borrowing debt due within one year (USD) | Current ratio |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | $19.29M | $18.73M | $4.36M | (m) | $13.60M | (m) | $5.63M | (m) | 1.03× |
| 2026-04-30 | $19.22M | $19.92M | $4.87M | (m) | $13.18M | (m) | $6.90M | (m) | 0.96× |
| 2026-01-31 | $20.18M | $20.68M | $7.13M | (m) | $12.07M | (m) | $5.73M | (m) | 0.98× |
| 2025-10-31 | $21.33M | $22.14M | $8.52M | (m) | $11.54M | (m) | $5.99M | (m) | 0.96× |
| 2025-07-31 | $21.01M | $22.70M | $10.32M | (m) | $9.47M | (m) | $4.84M | (m) | 0.93× |
| 2025-04-30 | $22.36M | $23.85M | (m) | (m) | $11.20M | (m) | $4.25M | (m) | 0.94× |
| 2025-01-31 | $19.70M | $19.87M | $3.20M | (m) | $15.78M | (m) | $5.09M | (m) | 0.99× |
| 2024-10-31 | $14.08M | $18.86M | $2.75M | (m) | $10.47M | (m) | $4.85M | (m) | 0.75× |
| 2024-07-31 | $13.18M | $19.16M | $2.89M | (m) | $9.03M | (m) | $5.24M | (m) | 0.69× |
| 2024-04-30 | $13.64M | $21.54M | (m) | (m) | $9.53M | (m) | $5.80M | (m) | 0.63× |
| 2024-01-31 | $13.20M | $21.97M | $4.47M | (m) | $7.89M | (m) | $4.76M | (m) | 0.60× |
| 2023-10-31 | $14.02M | $20.95M | $5.51M | (m) | $7.72M | (m) | $4.54M | (m) | 0.67× |
| 2023-07-31 | $14.92M | $20.38M | $4.87M | (m) | $8.95M | (m) | $5.76M | (m) | 0.73× |
| 2023-04-30 | $19.46M | $21.73M | (m) | (m) | $8.01M | (m) | $5.33M | (m) | 0.90× |
| 2023-01-31 | $20.36M | $20.80M | $11.64M | (m) | $8.05M | (m) | $4.30M | (m) | 0.98× |
| 2022-10-31 | $20.61M | $18.74M | $10.83M | (m) | $8.95M | (m) | $4.61M | (m) | 1.10× |
| 2022-07-31 | $18.37M | $16.62M | $8.06M | (m) | $9.36M | (m) | $2.54M | (m) | 1.11× |
| 2022-04-30 | $19.66M | $17.48M | (m) | (m) | $9.51M | (m) | $2.87M | (m) | 1.13× |
| 2022-01-31 | $17.82M | $15.50M | $8.70M | (m) | $8.56M | (m) | $3.74M | (m) | 1.15× |
| 2021-10-31 | $13.70M | $12.46M | $4.78M | (m) | $8.19M | (m) | $3.48M | (m) | 1.10× |
| 2021-07-31 | $12.60M | $11.68M | $4.00M | (m) | $7.73M | (m) | $3.35M | (m) | 1.08× |
| 2021-04-30 | $12.63M | $11.20M | (m) | (m) | $6.99M | (m) | $1.89M | (m) | 1.13× |
| 2020-10-31 | $14.99M | $12.75M | $8.55M | (m) | $5.96M | (m) | $3.95M | (m) | 1.18× |
| 2020-07-31 | $12.34M | $11.09M | $6.94M | (m) | $5.04M | (m) | $2.67M | (m) | 1.11× |
| 2020-04-30 | $13.50M | $12.30M | (m) | (m) | $4.77M | (m) | $3.14M | (m) | 1.10× |
| 2020-01-31 | $8.13M | $8.45M | $3.28M | (m) | $4.49M | (m) | $2.21M | (m) | 0.96× |
| 2019-10-31 | $7.07M | $8.25M | $2.78M | (m) | $3.92M | (m) | $2.79M | (m) | 0.86× |
| 2019-07-31 | $6.35M | $7.93M | $2.20M | (m) | $3.89M | (m) | $2.73M | (m) | 0.80× |
| 2019-04-30 | $7.92M | $8.03M | (m) | (m) | $4.38M | (m) | $2.81M | (m) | 0.99× |
| 2019-01-31 | $7.53M | $7.70M | $3.31M | (m) | $3.92M | (m) | $2.12M | (m) | 0.98× |
| 2018-10-31 | $6.92M | $7.33M | $2.00M | (m) | $4.70M | (m) | $2.02M | (m) | 0.94× |
| 2018-07-31 | $5.03M | $6.88M | $1.02M | (m) | $3.77M | (m) | $2.12M | (m) | 0.73× |
| 2018-04-30 | $5.06M | $7.45M | $856.00K | (m) | $3.92M | (m) | $2.15M | (m) | 0.68× |
| 2018-01-31 | $4.19M | $6.18M | $1.06M | (m) | $2.94M | (m) | $1.96M | (m) | 0.68× |
| 2017-10-31 | $3.54M | $5.82M | $660.00K | (m) | $2.58M | (m) | $1.55M | (m) | 0.61× |
| 2017-07-31 | $3.46M | $6.02M | $430.00K | (m) | $2.67M | (m) | $1.73M | (m) | 0.57× |
| 2017-04-30 | $5.87M | $7.45M | $3.29M | (m) | $2.27M | (m) | $1.85M | (m) | 0.79× |
| 2017-01-31 | $6.05M | $5.27M | $3.49M | (m) | $2.03M | (m) | $1.32M | (m) | 1.15× |
| 2016-10-31 | $6.66M | $4.60M | $4.33M | (m) | $1.89M | (m) | $1.15M | (m) | 1.45× |
| 2016-07-31 | $6.44M | $4.43M | $4.46M | (m) | $1.63M | (m) | $1.51M | (m) | 1.46× |
| 2016-04-30 | $4.34M | $5.31M | $2.58M | (m) | $1.31M | (m) | $1.90M | (m) | 0.82× |
| 2016-01-31 | $5.81M | $4.65M | $3.29M | (m) | $2.10M | (m) | $1.51M | (m) | 1.25× |
| 2015-10-31 | $6.34M | $3.27M | $4.16M | (m) | $1.89M | (m) | $1.34M | (m) | 1.94× |
| 2015-07-31 | $8.58M | $3.76M | $6.76M | (m) | $1.46M | (m) | $1.44M | (m) | 2.28× |
| 2015-04-30 | $10.76M | $3.80M | $9.36M | (m) | $1.06M | (m) | $1.41M | (m) | 2.84× |
| 2015-01-31 | $1.53M | $6.27M | $182.00K | (m) | $1.09M | (m) | $1.36M | (m) | 0.24× |
| 2014-10-31 | $2.08M | $3.94M | $575.00K | (m) | $1.11M | (m) | $1.63M | (m) | 0.53× |
| 2014-07-31 | $4.43M | $3.38M | $3.05M | (m) | $925.00K | (m) | $1.33M | (m) | 1.31× |
| 2014-04-30 | $7.60M | $3.66M | $5.89M | (m) | $1.32M | (m) | $981.00K | (m) | 2.08× |
| 2014-01-31 | $9.22M | $3.74M | $5.81M | (m) | $3.12M | (m) | $937.00K | (m) | 2.47× |
| 2013-10-31 | $9.25M | $3.27M | $7.57M | (m) | $1.46M | (m) | $982.00K | (m) | 2.83× |
| 2013-07-31 | $9.40M | $2.17M | $7.37M | (m) | $1.78M | (m) | $976.00K | (m) | 4.32× |
| 2013-04-30 | $10.38M | $2.93M | $9.56M | (m) | $500.00K | (m) | $1.20M | (m) | 3.54× |
| 2013-01-31 | $11.71M | $2.68M | $10.77M | (m) | $642.00K | (m) | $1.10M | (m) | 4.36× |
| 2012-10-31 | $2.88M | $2.93M | $2.16M | (m) | $627.00K | (m) | $1.21M | (m) | 0.98× |
| 2012-07-31 | $3.76M | $2.55M | $2.92M | (m) | $639.00K | (m) | $1.29M | (m) | 1.47× |
| 2012-04-30 | $5.54M | $3.49M | $4.75M | (m) | $584.00K | (m) | $1.68M | (m) | 1.59× |
| 2012-01-31 | $7.59M | $3.47M | $6.48M | (m) | $497.00K | (m) | $1.62M | (m) | 2.19× |
| 2011-10-31 | $8.80M | $3.42M | $7.12M | (m) | $832.00K | (m) | $1.29M | (m) | 2.57× |
| 2011-07-31 | $10.92M | $3.84M | $8.84M | (m) | $1.24M | (m) | $1.50M | (m) | 2.84× |
| 2011-04-30 | $11.84M | $3.50M | $10.46M | (m) | $585.00K | (m) | $1.58M | (m) | 3.38× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |